DoD Reconstructive Transplant, Qualitative Research Validation and Implementation Award | HT942524RTRPQRVIA

Opportunity Information: Apply for HT942524RTRPQRVIA

The FY24 DoD Reconstructive Transplant, Qualitative Research Validation and Implementation Award (RTRP Qualitative Research Validation and Implementation Award) is a Department of Defense grant opportunity designed to move promising, RTRP-funded qualitative research outputs closer to real-world use in the vascularized composite allotransplantation (VCA) community. In this context, VCA refers to reconstructive transplants such as hand, face, or other complex tissue transplantation. The program is specifically focused on resources that were created through earlier RTRP-funded qualitative studies and are seen as highly meaningful or potentially high-impact for people affected by reconstructive transplant. These resources might include decision-support tools, educational materials, communication guides, care navigation resources, or other practical products grounded in lived experience and stakeholder perspectives. The key point is that these resources are not considered ready-to-deploy products yet; the award supports the additional research needed to validate them and determine the best ways to disseminate and integrate them into clinical or community settings.

The work supported under this mechanism is meant to be primarily qualitative in nature, reflecting the program's emphasis on understanding experiences, meanings, and real-world context rather than testing a narrow hypothesis. Applicants are expected to use rigorous qualitative methods, with a clearly stated theoretical basis (for example, interactionism, phenomenology, or critical theory) that shapes how the research problem is framed and how data are interpreted. If qualitative findings naturally point toward some quantification, a mixed-methods approach is allowed, but the qualitative component should remain central. The expectation is that the proposed research will build on earlier findings, deepen or broaden them, and produce results that are credible, trustworthy, and well documented, including transparent procedures for sampling, data collection, recording, and analysis. The program also stresses ongoing participant feedback during the project, especially when interpreting results and drawing conclusions, which aligns with best practices for ensuring that outputs remain meaningful and culturally appropriate to the people the resource is intended to serve.

A major theme of the award is implementation science, meaning the study of strategies and methods that help evidence-based resources get adopted and used effectively in clinical practice and community environments. Importantly, the award supports validation and implementation research, not the costs of implementing the resource at scale. In other words, the funds can support studying what dissemination channels work best, what barriers and facilitators exist in real settings, what adaptations are necessary for different user groups, and what best practices are needed for uptake, but it is not intended to pay for full rollout, operational deployment, or routine service delivery.

The opportunity requires applicants to show clear continuity with a prior RTRP-supported qualitative project. A required element is an Outcomes Statement (listed as Attachment 9) summarizing the previously funded work, including the accomplishments, outcomes, and the specific resource or resources that were produced. The application must then make a convincing case for how the earlier work justifies the next step: validating the resource and/or determining the most effective dissemination and implementation approaches. The proposed project must also address one or both of the FY24 RTRP Qualitative Research Focus Areas (the notice references these focus areas without listing them in the provided text, so applicants would need to align explicitly with the official focus area language in the full announcement).

Military relevance is a core requirement. Projects must be responsive to the health care needs of Service Members and/or Veterans recovering from traumatic injury, and they may also include relevance to family members, caregivers, clinicians, and the broader public. Collaboration with military clinicians and researchers is encouraged but not mandatory. The program also signals a strong interest in advancing women's health research and innovation, encouraging applicants to consider how reconstructive transplant may affect women uniquely, disproportionately, or differently from men, and to incorporate attention to sex as a biological variable when appropriate. Additionally, the DoD encourages leveraging Department of Defense and/or Department of Veterans Affairs resources, including multidisciplinary collaborations across academia, industry, military services, VA, and other federal partners. If a project depends on access to unique datasets, populations, or infrastructure, the application is expected to document that access at the time of submission and explain how it will be maintained throughout the study.

In terms of what is and is not allowed, clinical trials are explicitly not permitted. The announcement uses the federal regulatory definition of a clinical trial (45 CFR 46.102), emphasizing that studies where human subjects are prospectively assigned to an intervention to evaluate biomedical or behavioral outcomes are not allowed. However, clinical research is allowed as long as it is observational and does not evaluate the safety, effectiveness, or efficacy of an intervention. The announcement clarifies that allowable clinical research can include work with human subjects, identifiable human data or specimens, and observational epidemiologic, behavioral, outcomes, or health services research, so long as it stays outside the clinical trial definition.

Administratively, this is a discretionary funding opportunity administered by the Department of the Army through USAMRAA under CDMRP, using a grant instrument (31 USC 6304). Eligibility is described as unrestricted. The anticipated maximum total costs for the entire period of performance should not exceed $500,000. The program expects to fund approximately one award with an approximate total allotment of $500,000, making it a highly competitive, single-award opportunity where proposal quality, program priorities, and federal funding availability will strongly shape the outcome. The original closing date listed is October 23, 2024. Awards using FY24 funds are expected to be made no later than September 30, 2025, and those FY24 funds are expected to remain available for obligation/use until they expire on September 30, 2030, consistent with the funding's fiscal life cycle.

Overall, the award is best understood as a bridge mechanism: it is intended for teams that already produced a VCA-focused resource through earlier RTRP qualitative work and now need targeted, rigorous qualitative (or mixed-methods) validation and implementation-focused research to prepare that resource for eventual clinical and community adoption, especially in ways that matter to wounded Service Members, Veterans, and the people who support their recovery.

• The Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Reconstructive Transplant, Qualitative Research Validation and Implementation Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on 2024-08-16.
• Applicants must submit their applications by 2024-10-23. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Unrestricted.

Apply for HT942524RTRPQRVIA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: